ROSSI DINO A 4
4 · Krystal Biotech, Inc. · Filed Sep 25, 2017
Insider Transaction Report
Form 4
ROSSI DINO A
Director
Transactions
- Conversion
Series A Convertible Preferred Stock
2017-09-22−123,691→ 0 total→ Common Stock (123,691 underlying) - Conversion
Common Stock
2017-09-22+123,691→ 123,691 total
Holdings
- 18,949
Stock Option (Right to Buy)
Exercise: $8.79From: 2021-06-01Exp: 2027-06-01→ Common Stock (18,949 underlying)
Footnotes (1)
- [F1]The Series A convertible preferred stock converted on a one-to-one basis into 123,691 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.